Think Research Corporation
XTSX:THNK
Intrinsic Value
Think Research Corp. engages in the development of digital healthcare solutions. [ Read More ]
The intrinsic value of one THNK stock under the Base Case scenario is 0.898 CAD. Compared to the current market price of 0.315 CAD, Think Research Corporation is Undervalued by 65%.
Valuation Backtest
Think Research Corporation
Run backtest to discover the historical profit from buying and selling THNK stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Think Research Corporation
| Current Assets | 19.4m |
| Cash & Short-Term Investments | 3.7m |
| Receivables | 11.2m |
| Other Current Assets | 4.4m |
| Non-Current Assets | 95.3m |
| PP&E | 10.1m |
| Intangibles | 75.8m |
| Other Non-Current Assets | 9.4m |
| Current Liabilities | 59.8m |
| Accounts Payable | 19.8m |
| Other Current Liabilities | 40m |
| Non-Current Liabilities | 26.9m |
| Long-Term Debt | 21.6m |
| Other Non-Current Liabilities | 5.2m |
Earnings Waterfall
Think Research Corporation
|
Revenue
|
85.1m
CAD
|
|
Cost of Revenue
|
-43.1m
CAD
|
|
Gross Profit
|
42m
CAD
|
|
Operating Expenses
|
-54.8m
CAD
|
|
Operating Income
|
-12.8m
CAD
|
|
Other Expenses
|
-2.5m
CAD
|
|
Net Income
|
-15.3m
CAD
|
Free Cash Flow Analysis
Think Research Corporation
THNK Profitability Score
Profitability Due Diligence
Think Research Corporation's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
Score
Think Research Corporation's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
THNK Solvency Score
Solvency Due Diligence
Think Research Corporation's solvency score is 21/100. The higher the solvency score, the more solvent the company is.
Score
Think Research Corporation's solvency score is 21/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
THNK Price Targets Summary
Think Research Corporation
According to Wall Street analysts, the average 1-year price target for THNK is 0.51 CAD with a low forecast of 0.505 CAD and a high forecast of 0.525 CAD.
Shareholder Return
THNK Price
Think Research Corporation
| Average Annual Return | -50.66% |
| Standard Deviation of Annual Returns | 34.61% |
| Max Drawdown | -97% |
| Market Capitalization | 24.7m CAD |
| Shares Outstanding | 78 800 000 |
| Percentage of Shares Shorted | 0.29% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Think Research Corp. engages in the development of digital healthcare solutions. The company is headquartered in Toronto, Ontario. The company went IPO on 2019-07-04. The firm gathers, develops and delivers knowledge-based Software-as-a-Service (SaaS) solutions globally to customers, which includes enterprise clients, hospitals, health regions, healthcare professionals and governments. The Company’s Order Sets product enables standardization for individual clinicians in delivering patient-centered care with data-driven analytics. Its Progress Notes product provides frontline clinical teams to align its documentation with a digital note shared across all team members. The Company’s eForms product replaces outdated paper forms with a digital solution letting to capture information. Its products and services are available in over 2,800 facilities across Canada, the United States, United Kingdom, European Union and the Middle East.
Contact
IPO
Employees
Officers
The intrinsic value of one THNK stock under the Base Case scenario is 0.898 CAD.
Compared to the current market price of 0.315 CAD, Think Research Corporation is Undervalued by 65%.
You don't have any saved screeners yet
